a month ago
LLY
AnalystsEmily FieldEmily Field's Stock Forecasts
AnalystsEmily Field
Sectors:
Industries:
Analyst Ranking
Top 44%
#2314 out of 5293 analysts
Average Return
+7.28%
Win Rate
71%5 out of 7
Risk vs Reward
Poor
Good
Emily Field's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Argenx SeARGX | +27.02% | $295.58 | $375.44 | 2021-10-18 - 2022-10-18 | Strong Buy |
Eli Lilly & CoLLY | +15.76% | $988.87 | $1,144.68 | 2026-05-04 - 2026-06-09 | Strong Buy |
Eli Lilly & CoLLY | +13.39% | $1,009.52 | $1,144.68 | 2026-02-19 - 2026-06-09 | Strong Buy |
Pfizer IncPFE | +3.56% | $26.65 | $25.70 | 2026-02-19 - 2026-06-09 | Strong Sell |
Abbvie IncABBV | +0.27% | $224.81 | $225.42 | 2026-02-19 - 2026-06-09 | Strong Buy |
Emily Field Analyst Color
Get additional color on Emily Field's coverage of popular stocks
4 months ago
MRK
4 months ago
LLY
Emily Field's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Eli Lilly & CoLLY | 2 | Strong Buy | $1,400.00 | +22.30% | Maintains | a month ago |
Pfizer IncPFE | 1 | Strong Sell | $25.00 | -2.72% | Initiates Coverage On | 4 months ago |
Merck & Co IncMRK | 1 | Strong Buy | $140.00 | +17.06% | Initiates Coverage On | 4 months ago |
Gilead Sciences IncGILD | 1 | Hold | $155.00 | +23.51% | Initiates Coverage On | 4 months ago |
Bristol Myers Squibb CoBMY | 1 | Strong Buy | $75.00 | +32.79% | Initiates Coverage On | 4 months ago |
Biogen IncBIIB | 1 | Hold | $185.00 | -7.08% | Initiates Coverage On | 4 months ago |
Amgen IncAMGN | 1 | Hold | $350.00 | +1.58% | Initiates Coverage On | 4 months ago |
Abbvie IncABBV | 1 | Strong Buy | $275.00 | +21.99% | Initiates Coverage On | 4 months ago |
Argenx SeARGX | 1 | Strong Buy | N/A | N/A | Upgrades | 5 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.